Skip to main content
Premium Trial:

Request an Annual Quote

Maverick Health to Offer Visby Medical Rapid Coronavirus Test

NEW YORK — Diagnostic testing services provider Maverick Health said on Friday that it has signed an agreement to offer Visby Medical's rapid point-of-care SARS-CoV-2 test.

The Visby Medical COVID-19 Point of Care Test is a single-use, fully integrated RT-PCR assay designed to detect SARS-CoV-2 nucleic acid, providing results within 30 minutes. It received Emergency Use Authorization from the US Food and Drug Administration in February for use with nasopharyngeal, anterior nasal, or mid-turbinate swabs collected by a health care provider or in anterior nasal or mid-turbinate swabs self-collected under the supervision of a healthcare provider. 

Under the terms of the agreement, Miami-based Maverick will provide the test to organizational partners, through its network of concierge testing sites in New York, Boston and Miami, and to customers for use at home.

Additional terms were not disclosed.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.